BUY SRF Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))15 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
SRF Q1 Results: Profit jumps 76%, board approves ₹250 crore capex; shares fall 3%
NewsCnbc-Tv18·22 Jul · today
SRF Q1 Results: Profit Surges 76%; Announces Dividend — Check Record Date
NewsNdtv-Profit·22 Jul · today
SRF Limited announced strong Q1FY27 financial results with a 32% increase in consolidated revenue to ₹5,033 crore and a 76% rise in Profit After Tax (PAT) to ₹759 crore compared to the previous year.
NSE · Press Release·22 Jul · today
SRF Ltd announced its Q1FY27 financial results, reporting a 32% increase in consolidated revenue to ₹5,033 crore and a 76% rise in Profit After Tax (PAT) to ₹759 crore compared to the previous year. T
BSE · Company Update·22 Jul · today
SRF Ltd has declared an interim dividend of Rs. 5 per share (50% of paid-up equity share capital). The dividend will be paid on or before August 18, 2026, to shareholders of record as of July 28, 2026
BSE · Board Meeting·22 Jul · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on SRF
- BUY — Nuvama Wealth23 Oct 2026 · ~1 year · target ₹2,905 · Active
- SELL — Citigroup23 Oct 2026 · ~1 year · target ₹2,225 · Active
- BUY — HSBC Securities23 Oct 2026 · ~1 year · target ₹3,275 · Active
- SELL — Kotak Securities23 Oct 2026 · ~1 year · target ₹2,225 · Active
- BUY — Mahesh Ojha, Kantilal Chhaganlal Securities22 Oct 2026 · ~3 months · target ₹2,400 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

